25 XP   0   0   10

Medipharm Labs Corp
Buy, Hold or Sell?

Let's analyse Medipharm Labs Corp together

PenkeI guess you are interested in Medipharm Labs Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Medipharm Labs Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Medipharm Labs Corp

I send you an email if I find something interesting about Medipharm Labs Corp.

Quick analysis of Medipharm Labs Corp (30 sec.)










What can you expect buying and holding a share of Medipharm Labs Corp? (30 sec.)

How much money do you get?

How much money do you get?
C$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
C$0.14
Expected worth in 1 year
C$0.12
How sure are you?
37.5%

+ What do you gain per year?

Total Gains per Share
C$-0.01
Return On Investment
-16.4%

For what price can you sell your share?

Current Price per Share
C$0.08
Expected price per share
C$0.08 - C$0.095
How sure are you?
50%

1. Valuation of Medipharm Labs Corp (5 min.)




Live pricePrice per Share (EOD)

C$0.08

Intrinsic Value Per Share

C$0.47 - C$0.59

Total Value Per Share

C$0.61 - C$0.72

2. Growth of Medipharm Labs Corp (5 min.)




Is Medipharm Labs Corp growing?

Current yearPrevious yearGrowGrow %
How rich?$40.6m$53m-$11.8m-28.8%

How much money is Medipharm Labs Corp making?

Current yearPrevious yearGrowGrow %
Making money-$2.8m-$8.4m$5.5m192.6%
Net Profit Margin-58.0%-211.4%--

How much money comes from the company's main activities?

3. Financial Health of Medipharm Labs Corp (5 min.)




What can you expect buying and holding a share of Medipharm Labs Corp? (5 min.)

Welcome investor! Medipharm Labs Corp's management wants to use your money to grow the business. In return you get a share of Medipharm Labs Corp.

What can you expect buying and holding a share of Medipharm Labs Corp?

First you should know what it really means to hold a share of Medipharm Labs Corp. And how you can make/lose money.

Speculation

The Price per Share of Medipharm Labs Corp is C$0.08. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Medipharm Labs Corp.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Medipharm Labs Corp, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is C$0.14. Based on the TTM, the Book Value Change Per Share is C$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is C$-0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is C$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Medipharm Labs Corp.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 C$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per Share
Usd Eps-0.01-9.9%-0.01-9.0%-0.02-26.5%-0.01-18.7%-0.01-15.9%
Usd Book Value Change Per Share-0.01-8.7%0.00-3.0%-0.02-24.2%0.016.3%0.005.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-8.7%0.00-3.0%-0.02-24.2%0.016.3%0.005.3%
Usd Price Per Share0.06-0.05-0.09-0.88-0.74-
Price to Earnings Ratio-1.74--1.83--1.27--26.42--22.02-
Price-to-Total Gains Ratio-7.91--5.51--5.47-22.46-22.46-
Price to Book Ratio0.55-0.49-0.69-6.46-5.38-
Price-to-Total Gains Ratio-7.91--5.51--5.47-22.46-22.46-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.058904
Number of shares16976
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.01
Usd Total Gains Per Share0.000.01
Gains per Quarter (16976 shares)-41.0885.31
Gains per Year (16976 shares)-164.31341.24
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-164-1740341331
20-329-3380682672
30-493-502010241013
40-657-666013651354
50-822-830017061695
60-986-994020472036
70-1150-1158023892377
80-1314-1322027302718
90-1479-1486030713059
100-1643-1650034123400

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%2.018.00.010.0%2.022.00.08.3%2.022.00.08.3%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%7.013.00.035.0%9.015.00.037.5%9.015.00.037.5%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.024.00.0%0.00.024.00.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%7.013.00.035.0%9.015.00.037.5%9.015.00.037.5%

Fundamentals of Medipharm Labs Corp

About Medipharm Labs Corp

MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. It also provides GMP flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll products. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.

Fundamental data was last updated by Penke on 2024-03-10 14:52:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Medipharm Labs Corp.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Medipharm Labs Corp earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Medipharm Labs Corp to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -50.9% means that $-0.51 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Medipharm Labs Corp:

  • The MRQ is -50.9%. The company is making a huge loss. -2
  • The TTM is -58.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-50.9%TTM-58.0%+7.1%
TTM-58.0%YOY-211.4%+153.4%
TTM-58.0%5Y-133.3%+75.4%
5Y-133.3%10Y-111.1%-22.2%
1.1.2. Return on Assets

Shows how efficient Medipharm Labs Corp is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Medipharm Labs Corp to the Drug Manufacturers - Specialty & Generic industry mean.
  • -6.4% Return on Assets means that Medipharm Labs Corp generated $-0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Medipharm Labs Corp:

  • The MRQ is -6.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -5.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.4%TTM-5.9%-0.5%
TTM-5.9%YOY-13.7%+7.8%
TTM-5.9%5Y-8.0%+2.1%
5Y-8.0%10Y-9.5%+1.6%
1.1.3. Return on Equity

Shows how efficient Medipharm Labs Corp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Medipharm Labs Corp to the Drug Manufacturers - Specialty & Generic industry mean.
  • -7.8% Return on Equity means Medipharm Labs Corp generated $-0.08 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Medipharm Labs Corp:

  • The MRQ is -7.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -7.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.8%TTM-7.0%-0.8%
TTM-7.0%YOY-15.5%+8.5%
TTM-7.0%5Y-10.1%+3.0%
5Y-10.1%10Y-11.4%+1.3%

1.2. Operating Efficiency of Medipharm Labs Corp.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Medipharm Labs Corp is operating .

  • Measures how much profit Medipharm Labs Corp makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Medipharm Labs Corp to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Medipharm Labs Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-52.3%+52.3%
TTM-52.3%YOY-214.6%+162.4%
TTM-52.3%5Y-130.0%+77.8%
5Y-130.0%10Y-108.4%-21.7%
1.2.2. Operating Ratio

Measures how efficient Medipharm Labs Corp is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 2.23 means that the operating costs are $2.23 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Medipharm Labs Corp:

  • The MRQ is 2.228. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.312. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.228TTM2.312-0.084
TTM2.312YOY2.889-0.577
TTM2.3125Y2.425-0.113
5Y2.42510Y2.021+0.404

1.3. Liquidity of Medipharm Labs Corp.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Medipharm Labs Corp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.27 means the company has $3.27 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Medipharm Labs Corp:

  • The MRQ is 3.275. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.316. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.275TTM4.316-1.041
TTM4.316YOY6.171-1.854
TTM4.3165Y4.396-0.080
5Y4.39610Y10.232-5.836
1.3.2. Quick Ratio

Measures if Medipharm Labs Corp is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Medipharm Labs Corp to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.63 means the company can pay off $0.63 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Medipharm Labs Corp:

  • The MRQ is 0.632. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 2.722. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.632TTM2.722-2.089
TTM2.722YOY4.441-1.719
TTM2.7225Y2.919-0.197
5Y2.91910Y15.225-12.306

1.4. Solvency of Medipharm Labs Corp.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Medipharm Labs Corp assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Medipharm Labs Corp to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.19 means that Medipharm Labs Corp assets are financed with 18.8% credit (debt) and the remaining percentage (100% - 18.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Medipharm Labs Corp:

  • The MRQ is 0.188. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.166. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.188TTM0.166+0.022
TTM0.166YOY0.121+0.045
TTM0.1665Y0.221-0.054
5Y0.22110Y0.190+0.031
1.4.2. Debt to Equity Ratio

Measures if Medipharm Labs Corp is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Medipharm Labs Corp to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 23.2% means that company has $0.23 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Medipharm Labs Corp:

  • The MRQ is 0.232. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.201. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.232TTM0.201+0.031
TTM0.201YOY0.139+0.062
TTM0.2015Y0.312-0.111
5Y0.31210Y0.266+0.046

2. Market Valuation of Medipharm Labs Corp

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Medipharm Labs Corp generates.

  • Above 15 is considered overpriced but always compare Medipharm Labs Corp to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -1.74 means the investor is paying $-1.74 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Medipharm Labs Corp:

  • The EOD is -1.855. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.739. Based on the earnings, the company is expensive. -2
  • The TTM is -1.827. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.855MRQ-1.739-0.116
MRQ-1.739TTM-1.827+0.088
TTM-1.827YOY-1.266-0.560
TTM-1.8275Y-26.424+24.598
5Y-26.42410Y-22.020-4.404
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Medipharm Labs Corp:

  • The EOD is -2.298. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.155. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.971. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.298MRQ-2.155-0.144
MRQ-2.155TTM-4.971+2.817
TTM-4.971YOY-2.698-2.274
TTM-4.9715Y-21.375+16.403
5Y-21.37510Y-17.812-3.562
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Medipharm Labs Corp is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Medipharm Labs Corp:

  • The EOD is 0.582. Based on the equity, the company is cheap. +2
  • The MRQ is 0.545. Based on the equity, the company is cheap. +2
  • The TTM is 0.486. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.582MRQ0.545+0.036
MRQ0.545TTM0.486+0.059
TTM0.486YOY0.693-0.207
TTM0.4865Y6.460-5.974
5Y6.46010Y5.383+1.077
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Medipharm Labs Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.009-0.003-65%-0.026+177%0.007-239%0.006-266%
Book Value Per Share--0.1380.139-1%0.180-23%0.212-35%0.177-22%
Current Ratio--3.2754.316-24%6.171-47%4.396-26%10.232-68%
Debt To Asset Ratio--0.1880.166+13%0.121+55%0.221-15%0.190-1%
Debt To Equity Ratio--0.2320.201+15%0.139+67%0.312-26%0.266-13%
Dividend Per Share----0%-0%-0%-0%
Eps---0.011-0.010-9%-0.029+167%-0.020+88%-0.017+61%
Free Cash Flow Per Share---0.009-0.009+5%-0.013+48%-0.019+119%-0.016+82%
Free Cash Flow To Equity Per Share---0.009-0.010+6%-0.012+29%-0.001-95%0.000-95%
Gross Profit Margin--1.0001.072-7%1.162-14%1.145-13%1.120-11%
Intrinsic Value_10Y_max--0.587--------
Intrinsic Value_10Y_min--0.472--------
Intrinsic Value_1Y_max---0.029--------
Intrinsic Value_1Y_min---0.028--------
Intrinsic Value_3Y_max---0.020--------
Intrinsic Value_3Y_min---0.020--------
Intrinsic Value_5Y_max--0.070--------
Intrinsic Value_5Y_min--0.059--------
Market Cap32102479.360+6%30096074.40027086466.960+11%51664927.720-42%481938471.392-94%401615392.827-93%
Net Profit Margin---0.509-0.580+14%-2.114+315%-1.333+162%-1.111+118%
Operating Margin----0.5230%-2.1460%-1.3000%-1.0840%
Operating Ratio--2.2282.312-4%2.889-23%2.425-8%2.021+10%
Pb Ratio0.582+6%0.5450.486+12%0.693-21%6.460-92%5.383-90%
Pe Ratio-1.855-7%-1.739-1.827+5%-1.266-27%-26.424+1420%-22.020+1166%
Price Per Share0.080+6%0.0750.068+11%0.129-42%1.201-94%1.001-93%
Price To Free Cash Flow Ratio-2.298-7%-2.155-4.971+131%-2.698+25%-21.375+892%-17.812+727%
Price To Total Gains Ratio-8.432-7%-7.905-5.514-30%-5.468-31%22.461-135%22.461-135%
Quick Ratio--0.6322.722-77%4.441-86%2.919-78%15.225-96%
Return On Assets---0.064-0.059-7%-0.137+115%-0.080+25%-0.095+50%
Return On Equity---0.078-0.070-10%-0.155+98%-0.101+28%-0.114+45%
Total Gains Per Share---0.009-0.003-65%-0.026+177%0.007-239%0.006-266%
Usd Book Value--40645968.90041211079.150-1%53077289.950-23%62757646.940-35%52353688.947-22%
Usd Book Value Change Per Share---0.007-0.002-65%-0.019+177%0.005-239%0.004-266%
Usd Book Value Per Share--0.1010.103-1%0.132-23%0.156-35%0.130-22%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.008-0.007-9%-0.021+167%-0.015+88%-0.013+61%
Usd Free Cash Flow---2571159.600-2695226.150+5%-3811456.950+48%-5624248.903+119%-4690007.564+82%
Usd Free Cash Flow Per Share---0.006-0.007+5%-0.009+48%-0.014+119%-0.012+82%
Usd Free Cash Flow To Equity Per Share---0.007-0.007+6%-0.009+29%0.000-95%0.000-95%
Usd Market Cap23637055.553+6%22159739.58119943765.623+11%38040886.280-42%354851296.486-94%295709413.738-93%
Usd Price Per Share0.059+6%0.0550.050+11%0.095-42%0.884-94%0.737-93%
Usd Profit---3185970.100-2894947.525-9%-8471499.650+166%-5905959.344+85%-4932127.516+55%
Usd Revenue--6262231.5005438864.025+15%4094564.300+53%8954181.115-30%7461817.596-16%
Usd Total Gains Per Share---0.007-0.002-65%-0.019+177%0.005-239%0.004-266%
 EOD+5 -3MRQTTM+11 -22YOY+20 -135Y+14 -1910Y+13 -20

3.2. Fundamental Score

Let's check the fundamental score of Medipharm Labs Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.855
Price to Book Ratio (EOD)Between0-10.582
Net Profit Margin (MRQ)Greater than0-0.509
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.632
Current Ratio (MRQ)Greater than13.275
Debt to Asset Ratio (MRQ)Less than10.188
Debt to Equity Ratio (MRQ)Less than10.232
Return on Equity (MRQ)Greater than0.15-0.078
Return on Assets (MRQ)Greater than0.05-0.064
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Medipharm Labs Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.790
Ma 20Greater thanMa 500.072
Ma 50Greater thanMa 1000.070
Ma 100Greater thanMa 2000.068
OpenGreater thanClose0.085
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CAD. All numbers in thousands.

Summary
Total Assets68,007
Total Liabilities12,804
Total Stockholder Equity55,203
 As reported
Total Liabilities 12,804
Total Stockholder Equity+ 55,203
Total Assets = 68,007

Assets

Total Assets68,007
Total Current Assets41,672
Long-term Assets26,335
Total Current Assets
Cash And Cash Equivalents 12,950
Net Receivables 8,046
Inventory 10,397
Other Current Assets 391
Total Current Assets  (as reported)41,672
Total Current Assets  (calculated)31,784
+/- 9,888
Long-term Assets
Property Plant Equipment 25,258
Intangible Assets 1,077
Long-term Assets  (as reported)26,335
Long-term Assets  (calculated)26,335
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities12,725
Long-term Liabilities79
Total Stockholder Equity55,203
Total Current Liabilities
Short Long Term Debt 2,463
Accounts payable 2,422
Other Current Liabilities 829
Total Current Liabilities  (as reported)12,725
Total Current Liabilities  (calculated)5,714
+/- 7,011
Long-term Liabilities
Long-term Liabilities  (as reported)79
Long-term Liabilities  (calculated)0
+/- 79
Total Stockholder Equity
Total Stockholder Equity (as reported)55,203
Total Stockholder Equity (calculated)0
+/- 55,203
Other
Capital Stock200,009
Common Stock Shares Outstanding 399,574
Net Invested Capital 57,666
Net Working Capital 28,947
Property Plant and Equipment Gross 52,033



Balance Sheet

Currency in CAD. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
> Total Assets 
0
400
384
525
509
461
42,729
70,138
174,319
183,024
168,830
143,775
178,765
150,227
118,231
137,328
128,184
118,199
92,361
84,580
79,241
71,234
65,495
62,051
73,522
68,007
68,00773,52262,05165,49571,23479,24184,58092,361118,199128,184137,328118,231150,227178,765143,775168,830183,024174,31970,13842,7294615095253844000
   > Total Current Assets 
0
400
384
525
509
461
26,614
45,650
142,922
140,853
119,701
93,351
127,656
101,008
81,521
101,624
94,023
84,883
65,547
58,300
54,309
52,182
47,345
44,366
46,702
41,672
41,67246,70244,36647,34552,18254,30958,30065,54784,88394,023101,62481,521101,008127,65693,351119,701140,853142,92245,65026,6144615095253844000
       Cash And Cash Equivalents 
0
400
362
520
509
461
7,850
8,400
72,723
42,116
38,627
21,366
27,946
36,458
19,913
42,124
38,751
37,958
34,110
28,273
21,992
19,454
24,145
20,150
14,742
12,950
12,95014,74220,15024,14519,45421,99228,27334,11037,95838,75142,12419,91336,45827,94621,36638,62742,11672,7238,4007,8504615095203624000
       Short-term Investments 
0
0
0
0
140
442
400
200
200
200
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000002002002004004421400000
       Net Receivables 
0
0
2
5
975
1,734
6,427
13,884
26,638
42,973
27,540
24,836
37,593
29,822
34,876
32,265
36,891
29,152
17,351
14,860
14,791
13,736
13,151
13,773
13,882
8,046
8,04613,88213,77313,15113,73614,79114,86017,35129,15236,89132,26534,87629,82237,59324,83627,54042,97326,63813,8846,4271,7349755200
       Other Current Assets 
0
0
21
0
674
1,837
2,332
565
937
1,478
2,048
2,056
21,788
3,045
4,593
1,007
3,841
2,476
4,745
2,354
4,472
9,799
2,273
1,490
4,311
391
3914,3111,4902,2739,7994,4722,3544,7452,4763,8411,0074,5933,04521,7882,0562,0481,4789375652,3321,83767402100
   > Long-term Assets 
0
0
0
0
0
0
0
24,488
31,397
42,171
49,129
50,424
51,109
49,219
36,710
35,704
34,161
33,316
26,814
26,280
24,932
19,052
18,150
17,685
26,820
26,335
26,33526,82017,68518,15019,05224,93226,28026,81433,31634,16135,70436,71049,21951,10950,42449,12942,17131,39724,4880000000
       Property Plant Equipment 
0
0
0
0
4,833
13,046
13,968
15,837
24,302
34,919
42,233
43,962
45,552
44,818
34,196
33,121
31,587
30,620
25,894
25,364
24,468
18,588
18,111
17,647
25,935
25,258
25,25825,93517,64718,11118,58824,46825,36425,89430,62031,58733,12134,19644,81845,55243,96242,23334,91924,30215,83713,96813,0464,8330000
       Long Term Investments 
0
0
0
0
50
50
81
157
189
189
189
191
191
191
191
191
191
191
0
0
0
0
0
0
0
0
000000001911911911911911911911891891891578150500000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
228
244
236
228
44
43
41
41
39
38
885
1,077
1,07788538394141434422823624422800000000000000
       Other Assets 
0
0
0
0
0
0
2,066
6,454
6,163
7,063
6,707
6,271
5,366
4,220
2,147
2,148
2,147
2,277
876
873
423
423
0
0
0
0
00004234238738762,2772,1472,1482,1474,2205,3666,2716,7077,0636,1636,4542,066000000
> Total Liabilities 
0
0
6
13
13
34
14,886
35,748
53,201
54,045
37,603
25,682
61,543
45,964
39,817
18,572
18,657
15,583
9,215
8,425
10,674
10,756
9,490
8,387
14,512
12,804
12,80414,5128,3879,49010,75610,6748,4259,21515,58318,65718,57239,81745,96461,54325,68237,60354,04553,20135,74814,886341313600
   > Total Current Liabilities 
0
0
6
13
13
34
14,886
35,748
53,201
53,561
28,846
25,129
39,949
14,661
24,245
17,906
18,391
15,457
8,877
8,104
10,383
10,706
9,456
8,369
12,684
12,725
12,72512,6848,3699,45610,70610,3838,1048,87715,45718,39117,90624,24514,66139,94925,12928,84653,56153,20135,74814,886341313600
       Short-term Debt 
0
0
0
0
0
0
0
6,000
6,000
6,361
1,823
9,704
1,628
7,740
7,697
3,400
2,006
2,148
113
69
1,374
1,119
598
200
963
0
09632005981,1191,374691132,1482,0063,4007,6977,7401,6289,7041,8236,3616,0006,0000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
6,000
6,000
6,000
1,459
9,351
1,257
7,382
7,375
3,102
1,732
1,968
0
0
1,291
1,038
523
131
963
2,463
2,4639631315231,0381,291001,9681,7323,1027,3757,3821,2579,3511,4596,0006,0006,0000000000
       Accounts payable 
0
0
0
13
2,946
4
8,094
20,356
43,605
41,636
19,057
11,697
5,646
2,116
5,549
2,646
6,628
5,976
2,991
2,795
3,519
3,694
3,539
2,389
3,722
2,422
2,4223,7222,3893,5393,6943,5192,7952,9915,9766,6282,6465,5492,1165,64611,69719,05741,63643,60520,3568,09442,94613000
       Other Current Liabilities 
0
0
6
0
13
30
50
650
3,596
5,564
7,966
3,728
32,675
4,805
9,996
9,803
8,258
5,633
4,452
3,714
3,986
4,608
3,998
4,496
1,387
829
8291,3874,4963,9984,6083,9863,7144,4525,6338,2589,8039,9964,80532,6753,7287,9665,5643,5966505030130600
   > Long-term Liabilities 
0
0
0
13
0
4
0
35,098
49,605
484
8,757
553
21,594
31,303
15,572
666
266
126
338
321
291
50
34
18
1,828
79
791,82818345029132133812626666615,57231,30321,5945538,75748449,60535,09804013000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
484
8,757
553
14,661
23,648
10,761
148
92
106
103
87
70
50
34
18
1,828
0
01,82818345070871031069214810,76123,64814,6615538,757484000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
6,933
7,655
4,811
518
174
20
235
234
221
0
0
0
0
0
00000221234235201745184,8117,6556,933000000000000
> Total Stockholder Equity
0
400
378
512
496
427
27,649
34,259
121,019
128,981
131,547
118,665
117,981
105,386
78,414
118,756
109,527
102,616
83,146
76,155
68,567
60,478
56,005
53,664
59,010
55,203
55,20359,01053,66456,00560,47868,56776,15583,146102,616109,527118,75678,414105,386117,981118,665131,547128,981121,01934,25927,6494274965123784000
   Common Stock
0
400
400
539
558
556
34,065
38,474
120,602
121,062
122,807
124,166
125,517
127,619
138,508
186,434
188,609
188,603
190,550
190,634
190,841
191,008
191,256
191,256
199,851
0
0199,851191,256191,256191,008190,841190,634190,550188,603188,609186,434138,508127,619125,517124,166122,807121,062120,60238,47434,0655565585394004000
   Retained Earnings Total Equity00000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
82
0
6,129
8,762
12,888
16,929
19,776
21,095
21,358
14,448
20,731
21,140
21,590
21,939
22,321
23,513
-4,069
28,398
29,145
0
0
0029,14528,398-4,06923,51322,32121,93921,59021,14020,73114,44821,35821,09519,77616,92912,8888,7626,12908200000
   Capital Surplus 00000000000000000000000000
   Treasury Stock00000000000000000000000000
   Other Stockholders Equity 
0
0
0
204
47
2,164
3,418
-14
-33
-32
16,929
19,776
21,095
21,358
14,448
20,731
21,140
21,590
21,939
22,321
23,513
27,256
0
29,145
-634
0
0-63429,145027,25623,51322,32121,93921,59021,14020,73114,44821,35821,09519,77616,929-32-33-143,4182,16447204000



Balance Sheet

Currency in CAD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue29,547
Cost of Revenue-25,677
Gross Profit3,8703,870
 
Operating Income (+$)
Gross Profit3,870
Operating Expense-49,036
Operating Income-19,489-45,166
 
Operating Expense (+$)
Research Development294
Selling General Administrative23,463
Selling And Marketing Expenses-
Operating Expense49,03623,757
 
Net Interest Income (+$)
Interest Income828
Interest Expense-274
Other Finance Cost-0
Net Interest Income554
 
Pretax Income (+$)
Operating Income-19,489
Net Interest Income554
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-15,736-22,688
EBIT - interestExpense = -274
-15,727
-15,453
Interest Expense274
Earnings Before Interest and Taxes (EBIT)--15,462
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-15,736
Tax Provision--9
Net Income From Continuing Ops-15,727-15,727
Net Income-15,727
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net3,199-554
 

Technical Analysis of Medipharm Labs Corp
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Medipharm Labs Corp. The general trend of Medipharm Labs Corp is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Medipharm Labs Corp's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Medipharm Labs Corp.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.095 < 0.095 < 0.095.

The bearish price targets are: 0.085 > 0.08 > 0.08.

Tweet this
Medipharm Labs Corp Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Medipharm Labs Corp. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Medipharm Labs Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Medipharm Labs Corp. The current macd is 0.0045186.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Medipharm Labs Corp price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Medipharm Labs Corp. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Medipharm Labs Corp price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Medipharm Labs Corp Daily Moving Average Convergence/Divergence (MACD) ChartMedipharm Labs Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Medipharm Labs Corp. The current adx is 36.84.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Medipharm Labs Corp shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Medipharm Labs Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Medipharm Labs Corp. The current sar is 0.0699576.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Medipharm Labs Corp Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Medipharm Labs Corp. The current rsi is 55.79. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Medipharm Labs Corp Daily Relative Strength Index (RSI) ChartMedipharm Labs Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Medipharm Labs Corp. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Medipharm Labs Corp price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Medipharm Labs Corp Daily Stochastic Oscillator ChartMedipharm Labs Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Medipharm Labs Corp. The current cci is 88.89.

Medipharm Labs Corp Daily Commodity Channel Index (CCI) ChartMedipharm Labs Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Medipharm Labs Corp. The current cmo is 9.78871789.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Medipharm Labs Corp Daily Chande Momentum Oscillator (CMO) ChartMedipharm Labs Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Medipharm Labs Corp. The current willr is -57.14285714.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Medipharm Labs Corp is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Medipharm Labs Corp Daily Williams %R ChartMedipharm Labs Corp Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Medipharm Labs Corp.

Medipharm Labs Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Medipharm Labs Corp. The current atr is 0.00714529.

Medipharm Labs Corp Daily Average True Range (ATR) ChartMedipharm Labs Corp Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Medipharm Labs Corp. The current obv is -6,415,626.

Medipharm Labs Corp Daily On-Balance Volume (OBV) ChartMedipharm Labs Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Medipharm Labs Corp. The current mfi is 78.61.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Medipharm Labs Corp Daily Money Flow Index (MFI) ChartMedipharm Labs Corp Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Medipharm Labs Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-10STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-11-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-16MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-21MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-28ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside

6.3. Candlestick Patterns

Medipharm Labs Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Medipharm Labs Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.790
Ma 20Greater thanMa 500.072
Ma 50Greater thanMa 1000.070
Ma 100Greater thanMa 2000.068
OpenGreater thanClose0.085
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Medipharm Labs Corp with someone you think should read this too:
  • Are you bullish or bearish on Medipharm Labs Corp? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Medipharm Labs Corp? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Medipharm Labs Corp

I send you an email if I find something interesting about Medipharm Labs Corp.


Comments

How you think about this?

Leave a comment

Stay informed about Medipharm Labs Corp.

Receive notifications about Medipharm Labs Corp in your mailbox!